NCT03023657

Brief Summary

Severe brain injuries lead to disorders of consciousness after coma. During this awakening period, detection of arousal is critical to the adaptation of medical strategy, but global paralysis, including facial expression, make the clinical assessment very difficult. Emotional facial expressions are a significant part of this clinical assessment. They are both a landmark of the internal state of the patient (comfort versus discomfort) and a landmark of the relational level with his environment. Visible emotional facial expression is a large temporal phenomenon lasting a couple of seconds, while a microexpression is barely noticeable and very brief. These micro expressions are usually produced when one tried to voluntary hide emotional expressions. In this study, we hypothesize that some patients awakening from coma could still produce microexpression before being able to produce visible emotional facial expressions. This ability to produce micro-expression could be an early landmark of relational awakening in severe brain lesions.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2017

Shorter than P25 for not_applicable

Geographic Reach
1 country

2 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 13, 2017

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 18, 2017

Completed
5 months until next milestone

Study Start

First participant enrolled

June 23, 2017

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 16, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 16, 2017

Completed
Last Updated

September 14, 2022

Status Verified

September 1, 2022

Enrollment Period

4 months

First QC Date

January 13, 2017

Last Update Submit

September 12, 2022

Conditions

Keywords

arousalConsciousness Disordersvegetative stateminimally conscious state

Outcome Measures

Primary Outcomes (1)

  • facial micro expression found in at least one patient on one video recording

    Optical camera and thermal camera

    Every day for a week then once a week for four weeks

Study Arms (1)

Severe brain-damaged patient in coma awakening

EXPERIMENTAL

For each patient, video sessions of the face will be performed during a waking period, until the spontaneous macro-EFE (Emotional Facial Expression) reappears. The video sessions will be done without stimulation or with visual, auditory or tactile stimulation. The sessions will be daily for 7 days then weekly for a maximum duration of 4 weeks.

Other: Detection of arousal

Interventions

Detecting facial microexpression before visible facial expressions in patient with disorder of consciousness after severe brain injury

Severe brain-damaged patient in coma awakening

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Brain-damaged patient (stroke, traumatic brain injury, anoxia)
  • Disorder of consciousness (CRS-R≤ 10) more than 48h after stopping sedation
  • Patient without spontaneous or stimulated facial expressions

You may not qualify if:

  • Medically unstable patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Chu Saint-Etienne

Saint-Etienne, 42055, France

Location

Clinique Mutualiste Saint Etienne

Saint-Etienne, 42100, France

Location

MeSH Terms

Conditions

Consciousness DisordersPersistent Vegetative State

Condition Hierarchy (Ancestors)

Neurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental DisordersBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesUnconsciousness

Study Officials

  • Pascal GIRAUX, MDPhD

    CHU SAINT-ETIENNE

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 13, 2017

First Posted

January 18, 2017

Study Start

June 23, 2017

Primary Completion

October 16, 2017

Study Completion

October 16, 2017

Last Updated

September 14, 2022

Record last verified: 2022-09

Data Sharing

IPD Sharing
Will not share

Locations